Literature DB >> 28034994

MR Fingerprinting of Adult Brain Tumors: Initial Experience.

C Badve1, A Yu2, S Dastmalchian3, M Rogers2, D Ma3, Y Jiang4, S Margevicius5, S Pahwa3, Z Lu2, M Schluchter5, J Sunshine3, M Griswold3,4, A Sloan6, V Gulani3,4.   

Abstract

BACKGROUND AND
PURPOSE: MR fingerprinting allows rapid simultaneous quantification of T1 and T2 relaxation times. This study assessed the utility of MR fingerprinting in differentiating common types of adult intra-axial brain tumors.
MATERIALS AND METHODS: MR fingerprinting acquisition was performed in 31 patients with untreated intra-axial brain tumors: 17 glioblastomas, 6 World Health Organization grade II lower grade gliomas, and 8 metastases. T1, T2 of the solid tumor, immediate peritumoral white matter, and contralateral white matter were summarized within each ROI. Statistical comparisons on mean, SD, skewness, and kurtosis were performed by using the univariate Wilcoxon rank sum test across various tumor types. Bonferroni correction was used to correct for multiple-comparison testing. Multivariable logistic regression analysis was performed for discrimination between glioblastomas and metastases, and area under the receiver operator curve was calculated.
RESULTS: Mean T2 values could differentiate solid tumor regions of lower grade gliomas from metastases (mean, 172 ± 53 ms, and 105 ± 27 ms, respectively; P = .004, significant after Bonferroni correction). The mean T1 of peritumoral white matter surrounding lower grade gliomas differed from peritumoral white matter around glioblastomas (mean, 1066 ± 218 ms, and 1578 ± 331 ms, respectively; P = .004, significant after Bonferroni correction). Logistic regression analysis revealed that the mean T2 of solid tumor offered the best separation between glioblastomas and metastases with an area under the curve of 0.86 (95% CI, 0.69-1.00; P < .0001).
CONCLUSIONS: MR fingerprinting allows rapid simultaneous T1 and T2 measurement in brain tumors and surrounding tissues. MR fingerprinting-based relaxometry can identify quantitative differences between solid tumor regions of lower grade gliomas and metastases and between peritumoral regions of glioblastomas and lower grade gliomas.
© 2017 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2016        PMID: 28034994      PMCID: PMC5352493          DOI: 10.3174/ajnr.A5035

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  51 in total

1.  Tissue characterization of intracranial tumors by MR imaging. In vivo evaluation of T1- and T2-relaxation behavior at 1.5 T.

Authors:  L Kjaer; C Thomsen; F Gjerris; B Mosdal; O Henriksen
Journal:  Acta Radiol       Date:  1991-11       Impact factor: 1.990

2.  Quantitative T2 mapping of recurrent glioblastoma under bevacizumab improves monitoring for non-enhancing tumor progression and predicts overall survival.

Authors:  Elke Hattingen; Alina Jurcoane; Keivan Daneshvar; Ulrich Pilatus; Michel Mittelbronn; Joachim P Steinbach; Oliver Bähr
Journal:  Neuro Oncol       Date:  2013-08-07       Impact factor: 12.300

3.  Epidemiology of brain metastases.

Authors:  Lakshmi Nayak; Eudocia Quant Lee; Patrick Y Wen
Journal:  Curr Oncol Rep       Date:  2012-02       Impact factor: 5.075

Review 4.  Quantitative relaxometry of the brain.

Authors:  Sean C L Deoni
Journal:  Top Magn Reson Imaging       Date:  2010-04

5.  Repeatability of magnetic resonance fingerprinting T1 and T2 estimates assessed using the ISMRM/NIST MRI system phantom.

Authors:  Yun Jiang; Dan Ma; Kathryn E Keenan; Karl F Stupic; Vikas Gulani; Mark A Griswold
Journal:  Magn Reson Med       Date:  2016-10-27       Impact factor: 4.668

6.  Tryptophan PET in pretreatment delineation of newly-diagnosed gliomas: MRI and histopathologic correlates.

Authors:  David O Kamson; Csaba Juhász; Amy Buth; William J Kupsky; Geoffrey R Barger; Pulak K Chakraborty; Otto Muzik; Sandeep Mittal
Journal:  J Neurooncol       Date:  2013-01-09       Impact factor: 4.130

7.  The incidence and significance of multiple lesions in glioblastoma.

Authors:  Reena P Thomas; Linda W Xu; Robert M Lober; Gordon Li; Seema Nagpal
Journal:  J Neurooncol       Date:  2013-01-26       Impact factor: 4.130

Review 8.  Epidemiologic and molecular prognostic review of glioblastoma.

Authors:  Jigisha P Thakkar; Therese A Dolecek; Craig Horbinski; Quinn T Ostrom; Donita D Lightner; Jill S Barnholtz-Sloan; John L Villano
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-07-22       Impact factor: 4.254

9.  Differentiation of glioblastoma multiforme and single brain metastasis by peak height and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.

Authors:  S Cha; J M Lupo; M-H Chen; K R Lamborn; M W McDermott; M S Berger; S J Nelson; W P Dillon
Journal:  AJNR Am J Neuroradiol       Date:  2007 Jun-Jul       Impact factor: 3.825

10.  Correlation of in vitro infiltration with glioma histological type in organotypic brain slices.

Authors:  S Palfi; K R Swanson; S De Boüard; F Chrétien; R Oliveira; R K Gherardi; J M Kros; M Peschanski; C Christov
Journal:  Br J Cancer       Date:  2004-08-16       Impact factor: 7.640

View more
  49 in total

1.  Three-dimensional simultaneous brain T1 , T2 , and ADC mapping with MR Multitasking.

Authors:  Sen Ma; Christopher T Nguyen; Fei Han; Nan Wang; Zixin Deng; Nader Binesh; Franklin G Moser; Anthony G Christodoulou; Debiao Li
Journal:  Magn Reson Med       Date:  2019-11-25       Impact factor: 4.668

Review 2.  Magnetic resonance fingerprinting: an overview.

Authors:  Charit Tippareddy; Walter Zhao; Jeffrey L Sunshine; Mark Griswold; Dan Ma; Chaitra Badve
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-05-26       Impact factor: 9.236

3.  Magnetic resonance fingerprinting of the pancreas at 1.5 T and 3.0 T.

Authors:  Eva M Serrao; Dimitri A Kessler; Bruno Carmo; Lucian Beer; Kevin M Brindle; Guido Buonincontri; Ferdia A Gallagher; Fiona J Gilbert; Edmund Godfrey; Martin J Graves; Mary A McLean; Evis Sala; Rolf F Schulte; Joshua D Kaggie
Journal:  Sci Rep       Date:  2020-10-16       Impact factor: 4.379

4.  Intraoperative MR and Synthetic Imaging.

Authors:  M I Vargas; B M A Delattre; P Vayssiere; M Corniola; T Meling
Journal:  AJNR Am J Neuroradiol       Date:  2019-12-19       Impact factor: 3.825

5.  MR fingerprinting for rapid simultaneous T1 , T2 , and T1 ρ relaxation mapping of the human articular cartilage at 3T.

Authors:  Azadeh Sharafi; Marcelo V W Zibetti; Gregory Chang; Martijn Cloos; Ravinder R Regatte
Journal:  Magn Reson Med       Date:  2020-05-09       Impact factor: 4.668

Review 6.  Magnetic resonance fingerprinting review part 2: Technique and directions.

Authors:  Debra F McGivney; Rasim Boyacıoğlu; Yun Jiang; Megan E Poorman; Nicole Seiberlich; Vikas Gulani; Kathryn E Keenan; Mark A Griswold; Dan Ma
Journal:  J Magn Reson Imaging       Date:  2019-07-25       Impact factor: 4.813

7.  Machine Learning for Rapid Magnetic Resonance Fingerprinting Tissue Property Quantification.

Authors:  Jesse I Hamilton; Nicole Seiberlich
Journal:  Proc IEEE Inst Electr Electron Eng       Date:  2019-09-11       Impact factor: 10.961

8.  Whole-body MRI for metastatic cancer detection using T2 -weighted imaging with fat and fluid suppression.

Authors:  Xinzeng Wang; Ali Pirasteh; James Brugarolas; Neil M Rofsky; Robert E Lenkinski; Ivan Pedrosa; Ananth J Madhuranthakam
Journal:  Magn Reson Med       Date:  2018-02-14       Impact factor: 4.668

9.  T2 relaxometry mapping in demonstrating layered uterine architecture: parameter optimization and utility in endometrial carcinoma and adenomyosis: a feasibility study.

Authors:  Adarsh Ghosh; Tulika Singh; Rashmi Bagga; Radhika Srinivasan; Veenu Singla; Niranjan Khandelwal
Journal:  Br J Radiol       Date:  2017-10-27       Impact factor: 3.039

10.  "Real world" use of a highly reliable imaging sign: "T2-FLAIR mismatch" for identification of IDH mutant astrocytomas.

Authors:  Rajan Jain; Derek R Johnson; Sohil H Patel; Mauricio Castillo; Marion Smits; Martin J van den Bent; Andrew S Chi; Daniel P Cahill
Journal:  Neuro Oncol       Date:  2020-07-07       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.